Clinical and genetic analysis of a patient with Craniofrontonasal syndrome.
10.3760/cma.j.cn511374-20220830-00587
- Author:
Juan JIN
1
;
Yu LEI
;
Qian PU
;
Lei YU
Author Information
1. School of Clinical Medicine, Guizhou Medical University, Guiyang, Guizhou 550001, China. myyl2004@163.com.
- Publication Type:Journal Article
- MeSH:
Humans;
Child;
Female;
Pregnancy;
Adolescent;
Ephrin-B1/genetics*;
China;
Computational Biology;
Family;
Mutation
- From:
Chinese Journal of Medical Genetics
2023;40(6):706-710
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:To explore the clinical feature and genetic etiology of a patient with Craniofacial nasal syndrome (CNFS).
METHODS:A patient with CNFS who had presented at the Guiyang Maternal and Child Health Care Hospital on November 13, 2021 was selected as the study subject. Clinical data of the patient were collected. Peripheral venous blood samples were collected from the patient and her parents and subjected to trio-whole exome sequencing (trio-WES). Candidate variants were verified by Sanger sequencing and bioinformatic analysis.
RESULTS:The patient, a 15-year-old female, had predominantly featured forehead bulging, hypertelorism, wide nasal dorsum and bifid nasal tip. Genetic testing revealed that she has harbored a heterozygous missense c.473T>C (p.M158T) variant of the EFNB1 gene, which was detected in either of her parents. By bioinformatic analysis, the variant has not been recorded in the HGMD and ClinVar databases, and no population frequency was recorded in the 1000 Genomes, ExAC, gnomAD and Shenzhou Genome Data Cloud databases. As predicted by the REVEL online software, the variant can confer deleterious effects on the gene or its product. Analysis using UGENE software showed the corresponding amino acid to be highly conserved among various species. Analysis with AlphaFold2 software suggested that the variant may affect the 3D structure and function of the Ephrin-B1 protein. Based on the American College of Medical Genetics and Genomics (ACMG) standards and guidelines and recommendation of Clinical Genome Resource (ClinGen), the variant was rated as pathogenic.
CONCLUSION:Combining the patient's clinical features and genetic finding, the diagnosis of CNFS was confirmed. The heterozygous c.473T>C (p.M158T) missense variant of the EFNB1 gene probably underlay the disease in this patient. Above finding has provided a basis for the genetic counseling and prenatal diagnosis for her family.
